Get the Stockscreener App
11.37
9.73%
-1.225
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $11.37, with a volume of 1.71M.
It is down -9.73% in the last 24 hours and down -32.19% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$12.59
Open:
$12.87
24h Volume:
1.71M
Relative Volume:
3.18
Market Cap:
$780.01M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-21.86
EPS:
-0.52
Net Cash Flow:
$-20.63M
1W Performance:
-33.65%
1M Performance:
-32.19%
6M Performance:
-10.23%
1Y Performance:
+90.05%
1-Day Range:
$11.23
$12.94
1-Week Range:
$11.00
$17.12
52-Week Range:
$5.65
$21.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
11.37 | 780.01M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
Breakeven On The Horizon For Axogen, Inc. (NASDAQ:AXGN) - simplywall.st
Balance Sheet Insights: Axogen Inc (AXGN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
AxoGen (NASDAQ:AXGN) Shares Gap Down on Disappointing Earnings - Defense World
Analysts Set AxoGen, Inc. (NASDAQ:AXGN) Target Price at $22.60 - Defense World
Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid Margin Challenges - GuruFocus
Axogen Reports Strong Q1 2025 Revenue Growth - TipRanks
AxoGen: Q1 Earnings Snapshot - Norwalk Hour
Earnings call transcript: AxoGen posts Q1 2025 loss, stock tumbles premarket - Investing.com
Axogen names Lindsey Hartley as new CFO By Investing.com - Investing.com India
AxoGen Q1 2025 Earnings Call Transcript - MarketBeat
AxoGen (AXGN) Price Target Reduced by Raymond James Analyst | AXGN Stock News - GuruFocus
Transcript : Axogen, Inc., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
AxoGen Q1 2025 Earnings Preview - MSN
What Analysts Were Expecting After Axogen Inc (NASDAQ: AXGN) fell -25.10% - Stocksregister
AxoGen reports Q1 adjusted EPS 2c, consensus 2c - TipRanks
Axogen (AXGN) Appoints New CFO Lindsey Hartley | AXGN Stock News - GuruFocus
Axogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Axogen (AXGN) Exceeds Q1 Revenue Expectations with Strong Growth | AXGN Stock News - GuruFocus
Axogen Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com India
Axogen Announces Chief Financial Officer Transition - The Manila Times
Axogen, Inc. Reports 2025 First Quarter Financial Results - The Manila Times
Axogen, Inc. Reports 2025 First Quarter Financial Results | AXGN Stock News - GuruFocus
Axogen names Lindsey Hartley as new CFO - Investing.com
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by MetLife Investment Management LLC - Defense World
Barclays PLC Has $1.27 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Invesco Ltd. Has $283,000 Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Renaissance Technologies LLC Acquires New Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Wells Fargo & Company MN Acquires 6,753 Shares of AxoGen, Inc. (NASDAQ:AXGN) - The AM Reporter
Did Axogen Inc (AXGN) perform well in the last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
LPL Financial LLC Buys New Shares in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
When (AXGN) Moves Investors should Listen - news.stocktradersdaily.com
AxoGen, Inc. to Host Earnings Call - ACCESS Newswire
Nerve Biologic Products Market Set to Witness Significant - openPR.com
Axogen, Inc. to report 2025 first quarter financial results on M - GuruFocus
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025 - The Manila Times
Axogen and ADMA Biologics expect low to zero impact from recent tariffs - MSN
AxoGen, Inc. (NASDAQ:AXGN) Stock Position Reduced by Geode Capital Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Alliancebernstein L.P. - Defense World
JPMorgan Chase & Co. Sells 238,432 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Would Axogen (NASDAQ:AXGN) Be Better Off With Less Debt? - simplywall.st
Analysts Set AxoGen, Inc. (NASDAQ:AXGN) PT at $22.60 - Defense World
American Century Companies Inc. Sells 20,635 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Sei Investments Co. Purchases New Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Financial Comparison: AxoGen (NASDAQ:AXGN) & QT Imaging (NASDAQ:QTI) - Defense World
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):